RapidAI announces software approval for Medicare New Technology Add-on Payment


rapidAI Rapid LVO FDA approvalRapidAI states Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP).

NTAP is part of the CMS Inpatient Prospective Payment System (IPPS). A significant advancement in stroke care and reimbursement for Medicare patients, the news further fuels the expansion of advanced stroke imaging for those technologies that meet the NTAP requirements, notes a company release.

The new NTAP programme applies to large vessel occlusion triage and notification for stroke. Rapid LVO explicitly meets the definition of measuring arterial blood flow in the brain per the issued NTAP code definition. RapidAI offers the most comprehensive stroke imaging platform available, the company release states. Once a large vessel occlusion is identified, Rapid ASPECTS can quantify the severity of the stroke, and Rapid CTP or Rapid MRI can then notify a stroke team if a patient is eligible for thrombectomy, it further outlines.

“Our mission can be simply stated…save lives, save time and save money,” said Don Listwin, CEO of RapidAI. “This exciting new development in Medicare reimbursement may at first seem like just a bookkeeping issue or just a win for RapidAI, the industry leader. However, in truth, this is not a step forward for any one company, but instead an advancement for various software technologies with the end goals of saving more lives and enabling better patient outcomes.”



Please enter your comment!
Please enter your name here